Stay updated with breaking news from Triple Combination. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The "Pulmonary Arterial Hypertension Market and Forecast Analysis to 2025" drug pipelines has been added to ResearchAndMarkets.com's offering.
Bio-Path Holdings Reports First Quarter 2021 Financial Results Conference Call to be Held Today at 8:30 A.M. ET HOUSTON, May 14, 2021 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize ® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced its financial results for the first quarter ended March 31, 2021 and provided an update on recent corporate developments. “The start of 2021 has been marked by substantial progress across our portfolio of targeted nu...
Granules India rose 1.57% to Rs 326.90 after the company said that US drug regulator has approved its Abbreviated New Drug Application (ANDA) for Acetaminophen, Aspirin and Caffeine Tablets USP, 250 mg/250 mg/65 mg (OTC).The product is bioequivalent to the reference listed drug product (RLD), Excedrin migraine tablets, 250 mg/250 mg/65 mg, of GlaxoSmithKline Consumer Healthcare. The drug is indicated for treating migraine. The product will be manufactured at the company's Hyderabad facility and is expected to be launched shortly. Priyanka Chigurupati, Executive Director, Granules Pharmaceuti...